Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum^℠

Program Overview

The goal of this activity is to educate physicians and other healthcare professionals on the appropriate management of patients with BCC at different disease stages.

Credit Expired

Target Audience

This activity is intended for oncology, dermatology, and dermato-oncology clinicians who manage patients with basal cell carcinoma (BCC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Distinguish between high- and low-risk BCC
Apply the current standard of care for treating high-risk BCC
Select appropriate front-line systemic therapy for advanced BCC
Evaluate emerging efficacy and safety data for immunotherapy in advanced BCC, offering clinical trial enrollment where appropriate

Activity Faculty

Prof. Ralf Gutzmer, MD (Chair)

Director
Department of Dermatology
Skin Cancer Center Minden
Johannes-Wesling-Klinikum Minden/Ruhr-University Bochum
Minden, Germany

Prof. Nicole Basset-Seguin, MD, PhD

Policlinique de Dermatologie
Hôpital Saint-Louis
Université de Paris
Paris, France

Omid Hamid, MD

Chief of Research/Immuno-Oncology
The Angeles Clinic & Research Institute
Co-Director, Cutaneous Malignancy Program
Cedars-Sinai CANCER
Los Angeles, California, United States

Thomas Hunter (Patient)

Featured RMEI CE Activities – Earn CE Credit(s)

A Non-CME Educational Program during the 2025 AAAAI/WAO Joint Congress: Expert Panel Discussion Featuring a Patient

A Violent Graft in a Vulnerable Host: The Future of aGvHD Management: A Care Team Forum®

1.5 CE Credit(s)

Rapid Recognition and Management of T-Cell Therapy-Related Toxicities in B-Cell Lymphomas: Crucial Updates for the Emergency Department

1.0 CE Credit(s)

Privacy | Terms of Use

Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum℠